Europe approves Israeli prostate cancer treatment

Readers will remember (8th Jan) when the BBC finally recognized Israel’s Weizmann Institute Tookad prostate cancer treatment. Israel’s Steba Biotech has now been given approval to market Tookad in Europe.  The treatment is already approved for use in Israel and Mexico.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *